Home > K Ray Chaudhuri, EAN 2020 – Clinical Impact of COVID-19 on People With Parkinson’s Disease
COVID-19, Parkinson's Disease

K Ray Chaudhuri, EAN 2020 – Clinical Impact of COVID-19 on People With Parkinson’s Disease

Published Online: June 5th 2020

So pleased to have had an opportunity to catch-up with editorial board member, K Ray Chaudhuri (King’s Parkinson’s Centre, King’s College Hospital and Kings College London, UK), who shared his expert perspective on the clinical impact of COVID-19 on people with Parkinson’s disease.

Question
What is the clinical impact of COVID-19 on people with Parkinson’s disease? (0:05)

See also linked video: K Ray Chaudhuri, EAN 2020 – Personalising Parkinson’s Treatment During the COVID-19 Pandemic

Speaker disclosure: K Ray Chaudhuri has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media.

Filmed at the 6th Congress of the European Academy of Neurology (EAN) and 1st EAN Virtual Congress, May 2020.

Share this Video
Related Videos In Parkinson's Disease
  • Copied to clipboard!
    accredited arrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greyarrow-right-orangearrow-right-whitearrow-right-blueavatarcalendarchevron-down crosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmenumore_dots padlock person play_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-whiteticktimetranscriptup-arrowwebinar